
ANLON HEALTHCARE Latest Share Price (AHCL)
TODAY IN ONE LINE
AHCL jumped 4.3% on average volume, outperforming Nifty's -0.0% move, supported by recent strong earnings.
With a market cap of ₹1,113.52 Cr., it trades at a P/E of 50.94. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
ANLON HEALTHCARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 182.7% and Profit up 72.6%
- ●Healthy Operating MarginsOPM is structurally strong at 25.5%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.22x
- ●FII AccumulationFII holding increased by 1.35% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 54.8% YoY
- ●Promoter SellingPromoter holding decreased by 52.68% QoQ
Latest ANLON HEALTHCARE News
What changed recently?
Recent events, corporate actions, and announcements.
ANLON HEALTHCARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for ANLON HEALTHCARE, framed against the sector median so the premium or discount is obvious at a glance.
ANLON HEALTHCARE trades at a P/E of 50.94× and P/B of 4.12×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
ANLON HEALTHCARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for ANLON HEALTHCARE — derived from the latest tape, not yesterday's close.
ANLON HEALTHCARE last traded at ₹20.9 with an intraday range of ₹19.7–₹21 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹20.90| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 23.97 | +3.07 | +14.67% |
| R3 | 22.67 | +1.77 | +8.45% |
| R2 | 21.83 | +0.93 | +4.47% |
| R1 | 21.37 | +0.47 | +2.23% |
| PIVOT | 20.53 | -0.37 | -1.75% |
| CURRENT | 20.90 | — | — |
| S1 | 20.07 | -0.83 | -3.99% |
| S2 | 19.23 | -1.67 | -7.97% |
| S3 | 18.77 | -2.13 | -10.21% |
| S4 | 17.47 | -3.43 | -16.43% |
AHCL is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹19.7–₹20.77
Trading Above opening range, showing Bullishness
ANLON HEALTHCARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for ANLON HEALTHCARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
ANLON HEALTHCARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,113.52 Cr. and reported EPS of ₹0.69.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 172 |
| Other Income | — | 0 |
| Total Income | — | 172 |
| — | 105 | |
| Gross ProfitDerived | — | 67 |
| Gross Margin %Derived | — | 38.88% |
| — | 19 | |
| EBITDA (Operating Profit)Derived | — | 48 |
| OPM %Derived | — | 27.63% |
| — | 5 | |
| Profit Before Tax (PBT) | — | 43 |
| — | 13 | |
| Effective Tax %Derived | — | 31.57% |
| Total Profit for Period | — | 29 |
| Less: Non-controlling Interests | — | 1 |
| Net Profit (Owner's PAT)Derived | — | 29 |
| Net Profit Margin %Derived | — | 16.58% |
| Earnings Per Share (EPS ₹) | — | 0.54 |
| Diluted Shares Outstanding (Cr) | — | 53 |
| Other Comprehensive Income (Net of Tax) | — | -0 |
| Total Expenses (incl. D&A & Interest) | — | 130 |
| Material Cost % of RevenueDerived | — | 86.83% |
| Employee Cost % of RevenueDerived | — | 3.22% |
| Other Cost % of RevenueDerived | — | 8.03% |
| Interest Coverage (x)Derived | — | 12.30x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 172 | |
| Other Income | 0 | |
| Total Income | 172 | |
105 | ||
| Gross ProfitDerived | 67 | |
| Gross Margin %Derived | 38.88% | |
19 | ||
| EBITDA (Operating Profit)Derived | 48 | |
| OPM %Derived | 27.63% | |
5 | ||
| Profit Before Tax (PBT) | 43 | |
13 | ||
| Effective Tax %Derived | 31.57% | |
| Total Profit for Period | 29 | |
| Less: Non-controlling Interests | 1 | |
| Net Profit (Owner's PAT)Derived | 29 | |
| Net Profit Margin %Derived | 16.58% | |
| Earnings Per Share (EPS ₹) | 0.54 | |
| Diluted Shares Outstanding (Cr) | 53 | |
| Other Comprehensive Income (Net of Tax) | -0 | |
| Total Expenses (incl. D&A & Interest) | 130 | |
| Material Cost % of RevenueDerived | 86.83% | |
| Employee Cost % of RevenueDerived | 3.22% | |
| Other Cost % of RevenueDerived | 8.03% | |
| Interest Coverage (x)Derived | 12.30x |
ANLON HEALTHCARE segment analysis : revenue and profit mix.
Disclosed business segments at ANLON HEALTHCARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
ANLON HEALTHCARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for ANLON HEALTHCARE.
Our AI distills the core fundamental drivers supporting ANLON HEALTHCARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
ANLON HEALTHCARE's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. Bedrock invocation timeout
Flip Conditions.
Valuation risk. a P/E above 66 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
ANLON HEALTHCARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — ANLON HEALTHCARE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
ANLON HEALTHCARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for ANLON HEALTHCARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
ANLON HEALTHCARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for ANLON HEALTHCARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in ANLON HEALTHCARE stood at 18.1% of traded volume, against a 20-day average of 39.4%.
ANLON HEALTHCARE announcements: results, concalls, ratings, M&A.
Filings ANLON HEALTHCARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
ANLON HEALTHCARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 117 documents below.
Shareholders meeting
Anlon Healthcare Limited has informed the Exchange regarding Revised Proceedings of Annual General Meeting held on September 05, 2026
Shareholders meeting
Anlon Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 05, 2026. Further, the…
Shareholders meeting
Anlon Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 05, 2026
Copy of Newspaper Publication
Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Shareholders meeting
Anlon Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 05, 2026
Investor decks & rating reports.
ANLON HEALTHCARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue ANLON HEALTHCARE has declared, sequenced by announce and record date.
ANLON HEALTHCARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About ANLON HEALTHCARE: business, sector, key facts.
What ANLON HEALTHCARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
ANLON HEALTHCARE operates in the Pharmaceuticals industry under the Healthcare sector.

Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- AMBALALSA (AMBALALSA) Share PricePeer
- Top Gainers TodayScreener
- Other overvalued NSE stocksScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about ANLON HEALTHCARE (AHCL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of ANLON HEALTHCARE (AHCL)?
The current share price of ANLON HEALTHCARE (AHCL) is ₹20.90. Today, the stock has gained by ₹0.86 (4.29%), trading in a range of ₹19.70 to ₹21.00. The stock opened at ₹19.70 with a trading volume of 1,35,54,763 shares.
02Is ANLON HEALTHCARE stock a good investment for long-term?
ANLON HEALTHCARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,113.52 Cr., P/E ratio of 50.94, ROE of 13.26%, and ROCE of 12.22%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of ANLON HEALTHCARE stock?
The 52-week high price of ANLON HEALTHCARE (AHCL) is ₹161.00, while the 52-week low is ₹12.91. Currently trading at ₹20.90, the stock is 61.89% above its 52-week low and 87.02% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy ANLON HEALTHCARE stock at the current price?
Whether to buy ANLON HEALTHCARE stock at ₹20.90 depends on multiple factors. The stock is currently trading with a P/E ratio of 50.94 and P/B ratio of 4.12. Today's performance shows a gain of 4.29%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of ANLON HEALTHCARE and when is the next dividend?
ANLON HEALTHCARE offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹20.90, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of ANLON HEALTHCARE?
ANLON HEALTHCARE's key financial metrics include: P/E Ratio: 50.94, P/B Ratio: 4.12, ROE: 13.26%, ROCE: 12.22%, Dividend Yield: 0%, EPS: ₹0.69, Book Value: ₹5.11, and Debt-to-Equity: 0.22. The company's market cap stands at ₹1,113.52 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is ANLON HEALTHCARE stock performing today in the market?
ANLON HEALTHCARE stock opened at ₹19.70 and is currently trading at ₹20.90, showing a gain of ₹0.86 (4.29%). The intraday high is ₹21.00 and low is ₹19.70. The trading volume stands at 1,35,54,763 shares, indicating strong market participation today.
08What is the P/E ratio of ANLON HEALTHCARE and what does it indicate?
ANLON HEALTHCARE has a Price-to-Earnings (P/E) ratio of 50.94, which means investors are willing to pay 50.94 for every ₹1 of earnings. With an EPS of ₹0.69, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about ANLON HEALTHCARE (AHCL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.